TR201819578A2 - Fesoterodi̇n fumaratin tablet kompozi̇syonlari - Google Patents
Fesoterodi̇n fumaratin tablet kompozi̇syonlariInfo
- Publication number
- TR201819578A2 TR201819578A2 TR2018/19578A TR201819578A TR201819578A2 TR 201819578 A2 TR201819578 A2 TR 201819578A2 TR 2018/19578 A TR2018/19578 A TR 2018/19578A TR 201819578 A TR201819578 A TR 201819578A TR 201819578 A2 TR201819578 A2 TR 201819578A2
- Authority
- TR
- Turkey
- Prior art keywords
- tablet compositions
- fesoterodine fumarate
- fesoterodine
- fumarate
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Mevcut buluş; fesoterodin fumarat ve en az bir kaplama maddesi içeren, uzun süreli boyunca fesoterodin bozunmasına karşı stabil, uzatılmış salım sağlayantablet kompozisyonları ile ilgilidir. Mevcut buluş ayrıca, fesoterodin fumaratın uzatılmış salım sağlayantablet kompozisyonlarını hazırlamaya yönelik basit, hızlı, uygun maliyetli, zaman tasarrufu sağlayan ve endüstriyel olarak uygun bir yöntemle de ilgilidir.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/TR2018/050860 WO2019132832A1 (en) | 2017-12-25 | 2018-12-21 | Tablet compositions of fesoterodine fumarate |
EP18849451.2A EP3731829A1 (en) | 2017-12-25 | 2018-12-21 | Tablet compositions of fesoterodine fumarate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/21437A TR201721437A2 (tr) | 2017-12-25 | 2017-12-25 | Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201819578A2 true TR201819578A2 (tr) | 2019-07-22 |
Family
ID=67900979
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/21437A TR201721437A2 (tr) | 2017-12-25 | 2017-12-25 | Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari |
TR2018/19274A TR201819274A2 (tr) | 2017-12-25 | 2018-12-13 | Fesoterodi̇ni̇n uzatilmiş salim sağlayan kompozi̇syonlari |
TR2018/19312A TR201819312A2 (tr) | 2017-12-25 | 2018-12-13 | Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu |
TR2018/19578A TR201819578A2 (tr) | 2017-12-25 | 2018-12-17 | Fesoterodi̇n fumaratin tablet kompozi̇syonlari |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/21437A TR201721437A2 (tr) | 2017-12-25 | 2017-12-25 | Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari |
TR2018/19274A TR201819274A2 (tr) | 2017-12-25 | 2018-12-13 | Fesoterodi̇ni̇n uzatilmiş salim sağlayan kompozi̇syonlari |
TR2018/19312A TR201819312A2 (tr) | 2017-12-25 | 2018-12-13 | Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu |
Country Status (3)
Country | Link |
---|---|
EP (4) | EP3731825A2 (tr) |
TR (4) | TR201721437A2 (tr) |
WO (3) | WO2019209220A2 (tr) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0957073A1 (en) | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
DE29923134U1 (de) | 1999-11-16 | 2000-06-29 | Sanol Arznei Schwarz Gmbh | Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen |
CN101466371B (zh) * | 2006-06-09 | 2011-10-05 | 施瓦茨制药有限公司 | 含非索罗定的稳定的药用组合物 |
US7807715B2 (en) | 2006-06-09 | 2010-10-05 | Ucb Pharma Gmbh | Pharmaceutical compositions comprising fesoterodine |
WO2010043408A2 (de) | 2008-10-17 | 2010-04-22 | Ratiopharm Gmbh | Mikroverkapseltes fesoterodin |
EP2508173A1 (en) * | 2011-04-08 | 2012-10-10 | LEK Pharmaceuticals d.d. | Stabilized pharmaceutical composition comprising fesoterodine |
US20130236544A1 (en) * | 2012-03-08 | 2013-09-12 | Dr. Reddy's Laboratories Ltd. | Stable pharmaceutical compositions of fesoterodine |
US20150182629A1 (en) * | 2012-07-02 | 2015-07-02 | Hetero Research Foundation | Stable compositions of fesoterodine |
IN2013MU02631A (tr) * | 2013-08-12 | 2015-06-19 | Genepharm India Pvt Ltd |
-
2017
- 2017-12-25 TR TR2017/21437A patent/TR201721437A2/tr unknown
-
2018
- 2018-12-13 TR TR2018/19274A patent/TR201819274A2/tr unknown
- 2018-12-13 TR TR2018/19312A patent/TR201819312A2/tr unknown
- 2018-12-17 TR TR2018/19578A patent/TR201819578A2/tr unknown
- 2018-12-21 WO PCT/TR2018/050858 patent/WO2019209220A2/en unknown
- 2018-12-21 EP EP18911327.7A patent/EP3731825A2/en active Pending
- 2018-12-21 EP EP18915776.1A patent/EP3731826A2/en active Pending
- 2018-12-21 EP EP18913635.1A patent/EP3731931A4/en active Pending
- 2018-12-21 WO PCT/TR2018/050859 patent/WO2019221684A2/en unknown
- 2018-12-21 WO PCT/TR2018/050855 patent/WO2019194772A2/en unknown
- 2018-12-21 EP EP18849451.2A patent/EP3731829A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2019194772A3 (en) | 2020-01-02 |
WO2019209220A3 (en) | 2019-12-26 |
TR201721437A2 (tr) | 2019-07-22 |
EP3731829A1 (en) | 2020-11-04 |
EP3731931A4 (en) | 2021-11-03 |
TR201819274A2 (tr) | 2019-07-22 |
WO2019194772A2 (en) | 2019-10-10 |
WO2019221684A3 (en) | 2020-01-30 |
EP3731826A2 (en) | 2020-11-04 |
WO2019221684A2 (en) | 2019-11-21 |
TR201819312A2 (tr) | 2019-07-22 |
WO2019194772A9 (en) | 2020-03-19 |
WO2019209220A2 (en) | 2019-10-31 |
EP3731931A2 (en) | 2020-11-04 |
EP3731825A2 (en) | 2020-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022015755A (es) | Profarmacos de hormona paratiroidea (pth). | |
PH12017502255A1 (en) | Nrf2 regulators | |
UY37134A (es) | Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4 | |
EA201892682A1 (ru) | Пестицидные композиции | |
MX2019011496A (es) | Composiciones de niraparib. | |
TR201901410T4 (tr) | Geliştirilmiş Laktam Çözünürlüğü | |
EA201790184A1 (ru) | Пестицидные композиции | |
MX2017008390A (es) | Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato. | |
MX2017015925A (es) | Trisiloxano organomodificado superdispersivo biodegradable. | |
BR112018006314A2 (pt) | composto da fórmula, composição, uso de composto da fórmula, método de combate a fungos fitopatogênicos e semente revestida | |
MX2018015410A (es) | Esteres de oxaborol y sus usos. | |
PL3582627T3 (pl) | Formulacje stabilne podczas przechowywania | |
MX358244B (es) | Composicion acondicionadora para el cuidado del cabello que comprende histidina. | |
MX360084B (es) | Composicion de champu que comprende matriz de gel e histidina. | |
MX2021007914A (es) | Composiciones curables que comprenden poliolefinas insaturadas. | |
CR20140326A (es) | Composiciones farmacéuticas tópicas que comprenden bexateno y corticosteroides | |
EA032472B9 (ru) | Композиция для укладки волос | |
DK3733177T3 (da) | Sammensætning til hornhindebeskyttelse | |
MX2016009519A (es) | Uso de una composicion acondicionadora de cabello para estilizar el cabello. | |
TR201819578A2 (tr) | Fesoterodi̇n fumaratin tablet kompozi̇syonlari | |
MX2016009520A (es) | Composicion acondicionadora de cabello que comprende un zwitterion o material proteico. | |
IL283318A (en) | Methods for preparing nitrogen oxides of propanediol, preparations including them and their medical uses | |
NO20161574A1 (en) | Skiwax | |
PH12016501448B1 (en) | Antifungal composition | |
SG11202002933TA (en) | Compositions for booster vaccination against dengu |